NIH-funded research NIH-funded research

Nutrition and exercise plan to help overweight cancer survivors, using multi-omics to tailor care

Official title: Integration of multi-omics to predict and evaluate response during optimization of a nutrition intervention for cancer survivors with overweight and obesity

Funded at University of Colorado Denver · NIH-11457147 · Data updated 2026-11-12

A cancer survivorship program combines a tailored diet and exercise plan with multi-omics data to personalize care for adults with overweight or obesity.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startMarch 1, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$249,000
NIH project number4R00CA287061-03
Project IDNIH-11457147 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 and older who are cancer survivors with overweight or obesity and are engaged in survivorship care or an exercise oncology program.

Less likely to help

Individuals without overweight or obesity or those not in survivorship care may not benefit from this specific program.

What this research studies

This project aims to create a scalable nutrition and physical activity program called BfedBwell for cancer survivors who are overweight or obese. It will be implemented within an existing clinical exercise oncology program and enhanced by multi-omic data to capture how lifestyle changes affect biology. The study plans to examine how changes in diet and activity influence health outcomes and biological markers, with the goal of informing personalized survivorship care. The approach seeks to translate evidence-based behavior change into real-world clinical practice. The work is led by the University of Colorado Denver and focuses on adults in the survivorship phase.

Why it matters

Potential benefit: If successful, patients could receive a personalized nutrition and exercise plan that improves health and reduces risks after cancer treatment.

How similar studies have gone: Prior MHBC approaches have shown promise when integrated into care, but multi-omics personalization in survivorship is a newer, extending strategy.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Hill, Emily B. — University of Colorado Denver
  • Study coordinator: Hill, Emily B.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.